Creo Medical Group PLC (LON:CREO – Get Free Report)’s stock price reached a new 52-week low during mid-day trading on Wednesday . The company traded as low as GBX 10.06 ($0.13) and last traded at GBX 10.18 ($0.13), with a volume of 3910275 shares. The stock had previously closed at GBX 10.88 ($0.14).
Creo Medical Group Trading Down 6.4 %
The company has a quick ratio of 2.19, a current ratio of 3.24 and a debt-to-equity ratio of 29.96. The stock has a market capitalization of £41.17 million, a P/E ratio of -1.61 and a beta of 0.86. The firm’s 50-day simple moving average is GBX 14.85 and its 200 day simple moving average is GBX 17.78.
Insider Buying and Selling
In related news, insider Richard John Rees acquired 4,712 shares of the business’s stock in a transaction on Thursday, January 16th. The shares were purchased at an average price of GBX 19 ($0.24) per share, for a total transaction of £895.28 ($1,143.98). Insiders own 22.43% of the company’s stock.
About Creo Medical Group
Creo Medical is a medical device company focused on the development and commercialisation of minimally invasive electrosurgical devices, bringing advanced energy to endoscopy.
The Company’s vision is to improve patient outcomes through the development and commercialisation of a suite of electrosurgical medical devices, each enabled by CROMA, powered by Kamaptive.
Read More
- Five stocks we like better than Creo Medical Group
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Quantum Computing: The $6.5 Billion Opportunity You Can’t Ignore
- Insider Trading – What You Need to Know
- Are Tariffs Threatening Disney’s Comeback Story?
- How Can Investors Benefit From After-Hours Trading
- Is Alphabet a Generational Buying Opportunity at These Levels?
Receive News & Ratings for Creo Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Creo Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
